Why are we conducting this study?
Women with pre-existing diabetes have a high risk of adverse pregnancy outcomes. High glucose levels are teratogenic. The risk of congenital malformations increases exponentially the higher the HbA1c around the time of conception and 1st trimester. In Australia, women with pre-existing diabetes have a congenital malformation rate of 10%, over 3 times the rate for women without diabetes.
Unfortunately, approximately 50% of women with diabetes have unplanned pregnancies. This means that they miss out on the opportunity to optimise glycaemic control, start high dose folate and stop teratogenic medications.
What can we do to prevent this?
Effective contraception and education around pregnancy planning are essential in enabling women to plan their pregnancies and optimise their glycaemic management and other aspects of health before a pregnancy. Good preconception care has been shown to reduce the risk of congenital malformation by 71%, reduce the risk of perinatal mortality by 54%, lower neonatal intensive care admissions by 25% and lower 1st trimester HbA1c by a mean of 1.27%.
What are we asking you to do if you participate?
Will I be compensated for participating?
If you would like to find out more about this study please contact Associate Professor Emily Hibbert, Endocrinologist at Nepean Hospital and the University of Sydney:
Email: NBMLHD-EndoResearch@health.nsw.gov.au
Telephone: 02 4734 4754
Or click on the link below:
https://redcap.sydney.edu.au/surveys/?s=P3FW8AMP4MXFPH88
Ethics committee approval number: 2024/HE001564